Ian Nicholson is Chair of the Remuneration Committee. Ian has over 35 years’ international experience in management and transactions within the life sciences sector including as chairman of Bioventix plc, as operating partner at London-based Advent Life Sciences LLP, and 8 years as CEO of the privately held anti-fungal drug development company F2G Limited. Ian has worked extensively in licensing, mergers and acquisitions and market development in the UK, Europe and the USA.
Ian Nicholson
Latest news
-
Could heart medication or arthritis drugs be used to treat motor neuron disease?
-
Accelerating innovation to transform lung health in primary care
-
LifeArc-funded trial gives new hope for children with devastating rare genetic disorder